.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent breakthroughs in dermatology have introduced a new family of compounds designed for HEVR photoprotection. High-energy visible radiation (HEVR) induces significant oxidative stress and cumulative skin damage. However, most commercial sunscreens offer limited protection in this specific light region. Consequently, these new multifunctional filters represent a major advancement in clinical skin health technology.
Furthermore, these innovative compounds feature tunable absorption and enhanced photostability. Moreover, their improved solubility makes them ideal for various cosmetic formulations. Beyond simple light filtration, these agents provide robust antioxidant capacity. This dual action prevents the long-term damage typically associated with HEVR exposure. Therefore, clinicians can expect more comprehensive protection from these state-of-the-art formulations.
Studies show that these new preparations significantly outperform current commercial products. Researchers benchmarked the best-performing compounds against existing state-of-the-art standards. The results confirmed that these multifunctional sunscreens offer superior skin defense against visible light. Additionally, the improved stability ensures the product remains effective throughout the day. This discovery could revolutionize how we approach daily sun protection for diverse skin types across India.
Standard UV filters often ignore the visible light spectrum. HEVR penetrates deeper into the skin than UV rays, leading to hyperpigmentation and premature aging.
These sunscreens combine efficient light-blocking filters with powerful antioxidant properties. This combination neutralizes free radicals while simultaneously blocking harmful radiation across a broader spectrum.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Peñín B et al. Integrated Visible Light and Oxidant Protection Through Multifunctional Sunscreens. Adv Healthc Mater. 2026 Apr 04. doi: 10.1002/adhm.71125. PMID: 41934188.
Sadowska M, et al. Skin and scalp under exposure to high-energy visible light: the current perspective. NIH PMC. 2023.
Dumbuya H, et al. Visible Light Protection: Needs and Strategies for Diverse Patients. Dermatology Times. 2025.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study introduces multifunctional sunscreens with enhanced HEVR protection and antioxidant properties, outperforming existing commercial formulations....
5 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
